Objective: In the context of increasing cases despite vaccination campaigns, a survey was conducted in the Bangui population from January 17 to 26, 2022, to evaluate the strains of Severe Acute Respiratory Infection Coronavirus 2 (SARS-Cov-2) circulating in a healthy population. Materials and methods: This study was conducted by taking nasopharyngeal samples from randomly selected volunteers. Antigen detection was performed systematically, and RT-PCR was done on the positive samples. Results and discussion: We collected 2,554 samples. Thirty were found RT-PCR positive (1.2%) and sent for viral genome sequencing. Twenty-eight SARS-Cov-2 strains belonged to the Omicron type, and only 2 to the Delta type. Conclusion: Thus, infections were uncommon in the tested population, but the presence of Omicron and Delta types raises concerns that vaccination may not be effective in fighting the virus, and newly designed vaccines should be implemented to better protect the population at risk of infection and reinfection by these variants.
References
[1]
World Health Organization (2022) COVID-19 Weekly Epidemiological Update. https://www.who.int/publications/m/item/covid-19-weekly-epidemiological-update
[2]
Lina, B. (2022) Les différentes phases de l’évolution moléculaire et antigénique des virus SARS-CoV-2 au cours des 20 mois suivant son émergence. Bulletin de L’Académie Nationale de Médecine, 206, 87-99. https://doi.org/10.1016/j.banm.2021.11.002
[3]
Li, F., Liang, Z., Cui, S., Lv, B., Feng, Z., Xu, H., et al. (2022) Importation of Sars-Cov-2 Omicron Variant in Beijing, China. Biosafety and Health, 4, 150-153. https://doi.org/10.1016/j.bsheal.2022.04.003
[4]
Maisa, A., Spaccaferri, G., Fournier, L., Schaeffer, J., Deniau, J., Rolland, P., et al. (2022) First Cases of Omicron in France Are Exhibiting Mild Symptoms, November 2021-January 2022. Infectious Diseases Now, 52, 160-164. https://doi.org/10.1016/j.idnow.2022.02.003
[5]
Rahbari, R., Moradi, N. and Abdi, M. (2021) rRT-PCR for SARS-CoV-2: Analytical Considerations. Clinica Chimica Acta, 516, 1-7. https://doi.org/10.1016/j.cca.2021.01.011
[6]
Les, V. and Sant, T.D.E. (2021) Revue rapide sur les tests antigéniques automatisés de détection du SARS-CoV-2 sur prélèvement nasopharyngé. https://www.has-sante.fr/jcms/p_3261383/fr/revue-rapide-sur-les-tests-antigeniques-automatises-de-detection-du-sars-cov-2-sur-prelevement-nasopharynge
[7]
Mbow, M., Badara Dieye, P.A., Khady Ba, N., Cisse, M., Lo, G., Gningue, M., et al. (2021) Evaluation an Immunofluorescence-Based Antigen Test for Hospital Point-of-Care Diagnosis of SARS-CoV-2 Infection. Clinical Microbiology and Infectious Diseases, 6, 1-4. https://doi.org/10.15761/cmid.1000192
[8]
De, A. and De, M.I.E.N. (2021) Covid-19: Quels prélèvements pour quels tests? Bulletin de L’Académie Nationale de Médecine, 205, 435-438.
[9]
Ntagereka, P.B., Oyola, S.O., Baenyi, S.P., Rono, G.K., Birindwa, A.B., Shukuru, D.W., et al. (2022) Whole-Genome Sequencing of SARS-CoV-2 Reveals Diverse Mutations in Circulating α and δ Variants during the First, Second, and Third Waves of COVID-19 in South Kivu, East of the Democratic Republic of the Congo. International Journal of Infectious Diseases, 122, 136-143. https://doi.org/10.1016/j.ijid.2022.05.041
[10]
Solis, M. (2022) Situation épidémique en juin 2022, Évolution du SARS-CoV-2 et des variants, Intérêt du suivi sérologique et de l’immunité. Archives des Maladies Professionnelles et de L’Environnement, 83, Article No. 344. https://doi.org/10.1016/j.admp.2022.07.032
[11]
Pollán, M., Pérez-gómez, B., Pastor-barriuso, R., Oteo, J., Hernán, M.A., Pérez-olmeda, M. and Yotti, R. (2020) Articles Prevalence of SARS-CoV-2 in Spain (ENE-COVID): A Nationwide, Population-Based Seroepidemiological Study. Lancet, 6736, 1-11.
[12]
Friedberga, B., Royoa, J., Villieza, V., Daynieza, N. and Coudeneb, P. (2021) Réflexions sur la place du test antigénique Covid-19 à partir d’un résultat discordant. Revue Francophone des Laboratoires, 2021, 67-69. https://doi.org/10.1016/s1773-035x(21)00110-6
[13]
Hantz, S. (2020) Diagnostic biologique de l’infection à Sars-CoV-2: Stratégies et interprétation des résultats. Revue Francophone des Laboratoires, 2020, 48-56. https://doi.org/10.1016/s1773-035x(20)30313-0
[14]
Cremer, K., De Keukeleire, M., Chatzis, O., Frère, J., Renard, F., Van der Linder, D., et al. (2022) 305-DYNAtracs: SARS-CoV-2 Séroprevalence chez les enfants dans les écoles primaires belges. Revue d’Épidémiologie et de Santé Publique, 70, S157-S158. https://doi.org/10.1016/j.respe.2022.06.082
[15]
Massamba, B., Assane, S., Rokhaya, D., Dalahata, B. and Mamadou, C. (2024) Infection à Covid-19 en gériatrie au Sénégal. NPG Neurologie—Psychiatrie—Gériatrie, 24, 51-59. https://doi.org/10.1016/j.npg.2023.05.005
[16]
Lango-Yaya, E., Rawago, D.B., N’yetobouko, S., Koyaweda, G.W., Kaleb Kandou, J.E., Pounguinza, S., Bondom, R., Sombot, A.S., Feissona, R., Bobossi, C., Feïganazoui, D., Agboko, M.F., Senzongo, O., Kassini, H.M. and Rafai, C.D. (2020) Epidemiological and Biological Profile of Covid-19 at the National Laboratory of Clinical Biology and Public Health of Bangui Central African Republic: Cross-Sectional Study. Global Scientific Journal, 8, 581-590.
[17]
Manirakiza, A., Malaka, C., Yambiyo, B.M., Diemer, H.S.C., Namseneï, J., et al. (2021) Very High Relative Seroprevalence of Anti-SARS-CoV-2 Antibodies among Communities in Bangui, Central African Republic. https://doi.org/10.1101/2021.11.18.21266496
[18]
Lachâtre, M. and Launay, O. (2022) Vaccination COVID-19: Technologies vaccinales, Efficacité en vie réelle et spécificités. Médecine et Maladies Infectieuses Formation, 1, 129-135. https://doi.org/10.1016/j.mmifmc.2022.07.001
[19]
Manus, J. (2023) Un déficit immunitaire rare responsable de formes de Covid sévère chez le patient vacciné. Revue Francophone des Laboratoires, 2023, 8-9. https://doi.org/10.1016/s1773-035x(23)00007-2
[20]
Chippaux, J.P. (2023) Impact de la COVID-19 sur la santé publique en Afrique subsaharienne. Bulletin de L’Académie Nationale de Médecine, 207, 150-164. https://doi.org/10.1016/j.banm.2022.10.015
